Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
12 sept. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
12 sept. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
10 sept. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 sept. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
05 sept. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Announces Chief Financial Officer Transition
29 août 2024 07h00 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
26 août 2024 17h23 HE
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $128.3 million for Fiscal 2024; Year-Over-Year Increase of 24.2% ---- High Value Pipeline Continues to Advance Toward Commercialization ---- State-of-the-Art Technology...
ACH Foam Technologies Supplies Largest Continuous Section of Geofoam in US
15 janv. 2013 10h32 HE
|
ACH Foam Technologies
DENVER, CO--(Marketwire - Jan 15, 2013) - ACH Foam Technologies, headquartered in Denver, provided 500 truckloads of EPS geofoam for Salt Lake City's airport TRAX light rail extension -- now the...